Dedicated to Discovery. Committed to Care.

Monthly Spotlights

Cancer Research Awareness Month

Dana-Farber researcher Maria Murray adjusts a slide on a microscope

Dana-Farber researcher Maria Murray adjusts a slide on a microscope.

In 2007, the U.S. Congress designated May as National Cancer Research Month. At Dana-Farber, we're joining the American Association for Cancer Research's national campaign to raise awareness of the ways research institutions contribute to the prevention, treatment, and cure of cancer.

Dana-Farber has always linked research to cancer care. Sidney Farber, M.D., introduced the country's first research program in chemotherapy for children with cancer in 1947. Dr. Farber and his team were the first to accomplish temporary remissions of acute lymphocytic leukemia in children. They were also the first to attain remissions in Wilms' tumor of the kidney, boosting cure rates from 40 to 85 percent in their young patients.

Dr. Farber's Children's Cancer Research Foundation became the Dana-Farber Cancer Institute. Today, we remain dedicated his mission: Conducting research that brings new scientific knowledge "from the lab bench to the bedside." Explore the features below to learn more about how Dana-Farber translates cancer research into patient treatment.

Highlighted Research Areas

Clinical Trials

Clinical trials are one way researchers analyze new medical treatments. In a trial, doctors test new drugs, therapies, and diagnostic procedures in patients in hopes of one day improving care.
Entering a clinical trial: Is it right for you?

Cancer and Genetics

Understanding the genetic underpinnings of cancer gives researchers at Dana-Farber a better understanding of the biology and origins of the disease. It helps us identify at-risk individuals and develop new, more effective therapies for patients.

Tissue Banking

Tissue banking is storing leftover human tissue that has been removed during a medical procedure such as an operation, a biopsy, or a blood test. Scientists use tissues from these banks to study disease and find better ways to diagnose, prevent, and treat cancer in the future.
Photo gallery: How tissue banking works
Tissue Banking: Advancing Cancer Care

Research Stories

Patient Stories

  • James Bond — Multiple myeloma clinical trials saved my life

    James Bond

    Seventeen years ago, he was told he had multiple myeloma and three years to live — at the most. Thanks to experimental treatments in clinical trials at Dana-Farber, today he leads an active life. read more

  • Paul Keane — Clinical trials offer hope for the future

    Paul Keane

    While Paul Keane hopes that participating in clinical trials will lead to a cure for his multiple myeloma, he takes some comfort in knowing his efforts will help others no matter the outcome. read more

  • Suzanne Blanchard — In memory of her daughter

    Suzanne Blanchard

    After losing her 37-year-old daughter to breast cancer, Suzanne Blanchard chose to participate in a national clinical trial of women at increased risk of contracting the disease. She shares the story of her inspiration for enrolling in the study. read more

Cancer Research Awareness Quiz

In the future, cancer researchers will mostly likely classify tumors by:









More from the AACR

National Cancer Research Month logo

The American Association for Cancer Research (AACR) is celebrating Cancer Research Awareness month. For more on its campaign, visit the AACR's Web site.